Drug information for PALONOSETRON HYDROCHLORIDE
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; INJECTION
0.05MG/ML
Tentative Approval
PALONOSETRON HYDROCHLORIDE
palonosetron
DR REDDYS LABS LTD
201533
2011-11-21 Letter
INJECTABLE; INJECTION
0.25MG/5ML
Tentative Approval
PALONOSETRON HYDROCHLORIDE
palonosetron
DR REDDYS LABS LTD
"
INJECTABLE; INJECTION
0.075MG/1.5ML
Tentative Approval
PALONOSETRON HYDROCHLORIDE
palonosetron
TEVA PHARMS
90713
INJECTABLE; INJECTION
0.25MG/0.25ML
Tentative Approval
PALONOSETRON HYDROCHLORIDE
palonosetron
TEVA PHARMS
"
Drug Adverse Effects information for PALONOSETRON HYDROCHLORIDE
Role code
Indications
Reaction
# Reports
C
LUNG NEOPLASM MALIGNANT
BACK PAIN
3
C
MANTLE CELL LYMPHOMA
BLOOD ALKALINE PHOSPHATASE INCREASED
1
C
MANTLE CELL LYMPHOMA
FEBRILE NEUTROPENIA
1
C
MANTLE CELL LYMPHOMA
GAMMA-GLUTAMYLTRANSFERASE INCREASED
1
C
MANTLE CELL LYMPHOMA
GRANULOCYTE COUNT DECREASED
1
C
MANTLE CELL LYMPHOMA
HAEMOGLOBIN DECREASED
1
C
MANTLE CELL LYMPHOMA
HICCUPS
1
C
MANTLE CELL LYMPHOMA
HYPERKALAEMIA
1
C
MANTLE CELL LYMPHOMA
LYMPHOCYTE COUNT DECREASED
1
C
MANTLE CELL LYMPHOMA
NAUSEA
1
C
MANTLE CELL LYMPHOMA
NEUTROPENIA
1
C
MANTLE CELL LYMPHOMA
NEUTROPHIL COUNT DECREASED
1
C
MANTLE CELL LYMPHOMA
PLATELET COUNT DECREASED
1
C
MANTLE CELL LYMPHOMA
VASCULITIS
1
C
MANTLE CELL LYMPHOMA
WHITE BLOOD CELL COUNT DECREASED
1
C
NON-HODGKIN'S LYMPHOMA
DIABETES MELLITUS
1
C
NON-HODGKIN'S LYMPHOMA
HEPATIC FUNCTION ABNORMAL
2
C
NON-HODGKIN'S LYMPHOMA
LYMPHOCYTE COUNT DECREASED
2
C
NON-HODGKIN'S LYMPHOMA
NEUTROPHIL COUNT DECREASED
1
C
NON-HODGKIN'S LYMPHOMA
NON-HODGKIN'S LYMPHOMA
1
C
NON-HODGKIN'S LYMPHOMA
ORGANISING PNEUMONIA
2
C
NON-HODGKIN'S LYMPHOMA
PLATELET COUNT DECREASED
1
C
NON-HODGKIN'S LYMPHOMA
PNEUMONIA ESCHERICHIA
2
C
NON-HODGKIN'S LYMPHOMA
RENAL IMPAIRMENT
1
Ads by Google